These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30228372)

  • 1. The clinical importance of a cytokine network in the acute phase of sepsis.
    Matsumoto H; Ogura H; Shimizu K; Ikeda M; Hirose T; Matsuura H; Kang S; Takahashi K; Tanaka T; Shimazu T
    Sci Rep; 2018 Sep; 8(1):13995. PubMed ID: 30228372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocytokine Profile Reveals Resistin Forming a Prognostic-Related Cytokine Network in the Acute Phase of Sepsis.
    Ebihara T; Matsumoto H; Matsubara T; Matsuura H; Hirose T; Shimizu K; Ogura H; Kang S; Tanaka T; Shimazu T
    Shock; 2021 Nov; 56(5):718-726. PubMed ID: 33606478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Importance of a Cytokine Network in Major Burns.
    Matsuura H; Matsumoto H; Osuka A; Ogura H; Shimizu K; Kang S; Tanaka T; Ueyama M; Shimazu T
    Shock; 2019 Feb; 51(2):185-193. PubMed ID: 29621119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective comparison of new Japanese Association for Acute Medicine (JAAM) DIC and International Society of Thrombosis and Hemostasis (ISTH) DIC score in critically ill septic patients.
    Singh RK; Baronia AK; Sahoo JN; Sharma S; Naval R; Pandey CM; Poddar B; Azim A; Gurjar M
    Thromb Res; 2012 Apr; 129(4):e119-25. PubMed ID: 22138415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis.
    Bozza FA; Salluh JI; Japiassu AM; Soares M; Assis EF; Gomes RN; Bozza MT; Castro-Faria-Neto HC; Bozza PT
    Crit Care; 2007; 11(2):R49. PubMed ID: 17448250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune dysfunction in cirrhosis: Distinct cytokines phenotypes according to cirrhosis severity.
    Dirchwolf M; Podhorzer A; Marino M; Shulman C; Cartier M; Zunino M; Paz S; Muñoz A; Bocassi A; Gimenez J; Di Pietro L; Romero G; Fainboim H; Fainboim L
    Cytokine; 2016 Jan; 77():14-25. PubMed ID: 26517154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 35 contributes to immunosuppression by regulating inflammatory cytokines and T cell populations in the acute phase of sepsis.
    Wu D; Wang L; Hong D; Zheng C; Zeng Y; Ma H; Lin J; Chen J; Zheng R
    Clin Immunol; 2022 Feb; 235():108915. PubMed ID: 34995813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Prognosis of Sepsis Based on Use of Cytokines, Chemokines, and Growth Factors.
    Jekarl DW; Kim JY; Ha JH; Lee S; Yoo J; Kim M; Kim Y
    Dis Markers; 2019; 2019():1089107. PubMed ID: 31583025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker Profile of Sepsis-Associated Coagulopathy Using Biochip Assay for Inflammatory Cytokines.
    Walborn A; Hoppensteadt D; Syed D; Mosier M; Fareed J
    Clin Appl Thromb Hemost; 2018 May; 24(4):625-632. PubMed ID: 28514870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating syndecan-1 predicts the development of disseminated intravascular coagulation in patients with sepsis.
    Ikeda M; Matsumoto H; Ogura H; Hirose T; Shimizu K; Yamamoto K; Maruyama I; Shimazu T
    J Crit Care; 2018 Feb; 43():48-53. PubMed ID: 28843664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.
    Kushimoto S; Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Endo S; Shimazaki S;
    Thromb Haemost; 2008 Dec; 100(6):1099-105. PubMed ID: 19132236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of a new criteria for sepsis-induced coagulopathy and International Society on Thrombosis and Haemostasis disseminated intravascular coagulation score in critically ill patients with sepsis 3.0: a retrospective study.
    Ding R; Wang Z; Lin Y; Liu B; Zhang Z; Ma X
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):551-558. PubMed ID: 30015646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early increases in serum FGF21 levels predict mortality of septic patients.
    Li X; Zhu Z; Zhou T; Cao X; Lu T; Liang Y; He J; Liu C; Dou Z; Shen B
    Cytokine; 2018 Nov; 111():428-433. PubMed ID: 29861384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating monocytes are not the major source of plasma cytokines in patients with sepsis.
    Gille-Johnson P; Smedman C; Gudmundsdotter L; Somell A; Nihlmark K; Paulie S; Andersson J; Gårdlund B
    Shock; 2012 Dec; 38(6):577-83. PubMed ID: 23143060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma kallistatin in critically ill patients with severe sepsis and septic shock.
    Lin WC; Chen CW; Chao L; Chao J; Lin YS
    PLoS One; 2017; 12(5):e0178387. PubMed ID: 28542440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance Evaluation of Five Different Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Predicting Mortality in Patients with Complicated Sepsis.
    Ha SO; Park SH; Hong SB; Jang S
    J Korean Med Sci; 2016 Nov; 31(11):1838-1845. PubMed ID: 27709865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating lncRNA NEAT1 correlates with increased risk, elevated severity and unfavorable prognosis in sepsis patients.
    Huang Q; Huang C; Luo Y; He F; Zhang R
    Am J Emerg Med; 2018 Sep; 36(9):1659-1663. PubMed ID: 29936011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
    Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
    J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Monocyte Chemoattractant Protein 1 as a Predictive Marker for Sepsis Prognosis: A Prospective Cohort Study.
    Zhu T; Liao X; Feng T; Wu Q; Zhang J; Cao X; Li H
    Tohoku J Exp Med; 2017 Feb; 241(2):139-147. PubMed ID: 28202856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of Tissue Factor and CD13 Double-Positive Microparticles in Sirs Patients with Trauma and Severe Sepsis.
    Matsumoto H; Yamakawa K; Ogura H; Koh T; Matsumoto N; Shimazu T
    Shock; 2017 Apr; 47(4):409-415. PubMed ID: 27753793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.